Web4 Mar 2024 · Atrial fibrillation in adults: Use of oral anticoagulants; Bioprosthetic valve thrombosis, thromboembolism, and obstruction: Management; Clinical manifestations of Staphylococcus aureus infection in adults; Clinical presentation and diagnosis of heparin-induced thrombocytopenia Web18 Nov 2024 · The direct oral anticoagulants (DOACs; dabigatran, factor Xa inhibitors [rivaroxaban, apixaban, edoxaban]) have shorter half-lives, making them easier to discontinue and resume rapidly. Our approach to managing ongoing anticoagulation in patients undergoing surgery or an invasive procedure is discussed here.
UpToDate
Web28 Jan 2024 · Management of heparin-induced thrombocytopenia; Management of heparin-induced thrombocytopenia (HIT) during cardiac or vascular surgery; Multiple myeloma: … WebHeparin was discovered by McLean in 1916. 15 More than 20 years later, Brinkhous and associates 16 demonstrated that heparin requires a plasma cofactor for its anticoagulant … hosts 文件修改
Anticoagulation Bridge Therapy in Patients with Atrial Fibrillation ...
WebPatients: In 231 patients with stroke and nonvalvular atrial fibrillation, intravenous or subcutaneous heparin administered with the goal of achieving an activated partial thromboplastin time (APTT) 1.5 to 2.0 times control values. Delay to the initiation of heparin therapy was less than 6 hours from the onset of symptoms in 74 patients and ... WebHeparin is a highly sulfated mucopolysaccharide. It is heterogeneous with respect to molecular size, anticoagulant activity, and pharmacokinetic properties ( Table 1 ). Heparin molecules range in molecular weight from 3,000 to 30,000 kDa with a mean of 15,000, which corresponds to approximately 45 saccharide units ( Fig 2 ). 8 , 9 , 10 WebThrombosis and bleeding risk tools have emerged to facilitate this assessment and have been incorporated into guideline recommendations. Results from ongoing trials are … hosts 場所 win10